Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Other Non Operating Income (2021 - 2026)

Invivyd's (IVVD) quarterly Other Non Operating Income came in at $1.4 million in Q2 2026, up 256.75% on a YoY basis from $400000.0 in Q2 2025, and down 3.91% quarter-over-quarter from $1.5 million in Q4 2025.

Analysis

Invivyd (IVVD) Other Non Operating Income (2021 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Other Non Operating Income for 6 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non Operating Income rose 256.75% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (up 13.98% YoY), and the FY2025 full-year result was $3.1 million, down 55.82% from the prior year.
  • Other Non Operating Income slipped to $1.4 million in Q2 2026 per IVVD's latest filing, from $1.5 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $3.8 million in Q1 2023 and bottomed at $73000.0 in Q1 2022.
  • Historically, Other Non Operating Income has averaged $1.9 million across 5 years, with a median of $1.6 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Other Non Operating Income jumped 7479.17% in 2022, then tumbled 80.0% in 2025.
  • Over 5 years, Other Non Operating Income stood at $3.6 million in 2022, then retreated by 14.84% to $3.1 million in 2023, then sank by 74.63% to $786000.0 in 2024, then jumped by 88.93% to $1.5 million in 2025, then fell by 3.91% to $1.4 million in 2026.
  • According to Business Quant data, Other Non Operating Income over the past three periods registered $1.4 million, $1.5 million, and $553000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.43 Mn
Dec 31, 2025 1.49 Mn
Sep 30, 2025 553,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 633,000.00
Dec 31, 2024 786,000.00
Sep 30, 2024 1.57 Mn
Jun 30, 2024 2.00 Mn
Mar 31, 2024 2.59 Mn
Dec 31, 2023 3.10 Mn
Sep 30, 2023 3.62 Mn
Jun 30, 2023 3.65 Mn
Mar 31, 2023 3.75 Mn
Dec 31, 2022 3.64 Mn
Sep 30, 2022 2.24 Mn
Jun 30, 2022 759,000.00
Mar 31, 2022 73,000.00
Dec 31, 2021 48,000.00
Sep 30, 2021 43,000.00
Jun 30, 2021 18,000.00